BVF Inc’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-724,418
Closed -$11.6M 59
2018
Q2
$11.6M Sell
724,418
-5,893,208
-89% -$87.2M 1.13% 27
2018
Q1
$85.5M Buy
+6,617,626
New +$82.5M 8.67% 2
2017
Q4
Sell
-3,367,080
Closed -$44.5M 44
2017
Q3
$44.5M Buy
+3,367,080
New +$46.3M 5.65% 7
2016
Q2
Sell
-2,096,360
Closed -$19.2M 35
2016
Q1
$19.2M Sell
2,096,360
-1,409,194
-40% -$11.6M 4.75% 10
2015
Q4
$34M Sell
3,505,554
-2,314,447
-40% -$22.4M 5.8% 7
2015
Q3
$50.8M Buy
5,820,001
+3,227,698
+125% +$30.1M 10.26% 1
2015
Q2
$26.2M Hold
2,592,303
4.62% 10
2015
Q1
$34.7M Sell
2,592,303
-3,489,706
-57% -$45.8M 7.26% 3
2014
Q4
$78M Sell
6,082,009
-600,887
-9% -$6.88M 15.18% 1
2014
Q3
$72.5M Sell
6,682,896
-4,312,541
-39% -$49.4M 15.06% 1
2014
Q2
$141M Sell
10,995,437
-112,349
-1% -$1.22M 22.33% 1
2014
Q1
$115M Sell
11,107,786
-325,539
-3% -$3.66M 17.77% 2
2013
Q4
$111M Buy
11,433,325
+2,005,428
+21% +$18M 19.45% 2
2013
Q3
$93.6M Buy
9,427,897
+3,156,339
+50% +$31M 16.1% 2
2013
Q2
$52.3M Buy
+6,271,558
New +$76M 10.14% 3

Other funds holding IRWD

BVF Inc's IRWD Position: Q3 2018 in Review

BVF Inc sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2018, closing a stake of 724,418 shares — an estimated $11.6M sold.

BVF Inc first reported a position in IRWD in Q2 2013 and held it in 15 quarters. The position peaked at $141M in Q2 2014. 151 funds tracked by Wall St. Rank hold IRWD as of Q3 2018.

  • BVF Inc reported no remaining Ironwood Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
  • BVF Inc sold 724,418 Ironwood Pharmaceuticals shares in Q3 2018, an estimated $11.6M.
  • BVF Inc first reported a position in Ironwood Pharmaceuticals in Q2 2013 and held it in 15 quarters.
  • BVF Inc's Ironwood Pharmaceuticals position peaked at $141M in Q2 2014.
  • 151 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2018.

Based on BVF Inc's 13F filing for Q3 2018, filed 14 Nov 2018.